Rxivist logo

Author: Mark J Mulligan

Rankings

  • All-time downloads: 665,111 (rank: 36 )
  • Categories:
    • immunology: 137,691 (rank: 36 )
    • infectious diseases: 489,947 (rank: 34 )
    • microbiology: 8,308 (rank: 2,689 )
    • neurology: 665 (rank: 4,472 (tie) )
    • public and global health: 17,201 (rank: 381 (tie) )
    • rheumatology: 2,432 (rank: 135 (tie) )
    • systems biology: 70 (rank: 18,515 (tie) )

Downloads per author, site-wide

Preprints

Molecularly distinct memory CD4+ T cells are induced by SARS-CoV-2 infection and mRNA vaccination

immunology more details view paper

No download data for this paper yet.

Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report

infectious diseases more details view paper
  • Downloaded 302,497 times
  • Download rankings, all-time:
    • Site-wide: 8
    • In infectious diseases: 6
  • Year to date:
    • Site-wide: 30
  • Since beginning of last month:
    • Site-wide: 105

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 84,200 times
  • Download rankings, all-time:
    • Site-wide: 103
    • In infectious diseases: 39
  • Year to date:
    • Site-wide: 469
  • Since beginning of last month:
    • Site-wide: 1,056

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 74,368 times
  • Download rankings, all-time:
    • Site-wide: 117
    • In infectious diseases: 46
  • Year to date:
    • Site-wide: 1,052
  • Since beginning of last month:
    • Site-wide: 1,286

Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants

immunology more details view paper
  • Downloaded 70,940 times
  • Download rankings, all-time:
    • Site-wide: 129
    • In immunology: 6
  • Year to date:
    • Site-wide: 236
  • Since beginning of last month:
    • Site-wide: 1,933

The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies.

immunology more details view paper
  • Downloaded 22,233 times
  • Download rankings, all-time:
    • Site-wide: 506
    • In immunology: 27
  • Year to date:
    • Site-wide: 5,259
  • Since beginning of last month:
    • Site-wide: 13,751

SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum

immunology more details view paper
  • Downloaded 19,635 times
  • Download rankings, all-time:
    • Site-wide: 583
    • In immunology: 28
  • Year to date:
    • Site-wide: 4,027
  • Since beginning of last month:
    • Site-wide: 9,661

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

public and global health more details view paper
  • Downloaded 17,402 times
  • Download rankings, all-time:
    • Site-wide: 671
    • In public and global health: 26
  • Year to date:
    • Site-wide: 4,145
  • Since beginning of last month:
    • Site-wide: 3,947

B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

immunology more details view paper
  • Downloaded 15,304 times
  • Download rankings, all-time:
    • Site-wide: 780
    • In immunology: 36
  • Year to date:
    • Site-wide: 2,183
  • Since beginning of last month:
    • Site-wide: 2,216

SARS-CoV-2 mRNA vaccine elicits a potent adaptive immune response in the absence of IFN-mediated inflammation observed in COVID-19

infectious diseases more details view paper
  • Downloaded 13,024 times
  • Download rankings, all-time:
    • Site-wide: 971
    • In infectious diseases: 323
  • Year to date:
    • Site-wide: 918
  • Since beginning of last month:
    • Site-wide: 4,561

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

immunology more details view paper
  • Downloaded 8,554 times
  • Download rankings, all-time:
    • Site-wide: 1,651
    • In immunology: 62
  • Year to date:
    • Site-wide: 5,116
  • Since beginning of last month:
    • Site-wide: 14,151

Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals

infectious diseases more details view paper
  • Downloaded 7,583 times
  • Download rankings, all-time:
    • Site-wide: 1,934
    • In infectious diseases: 558
  • Year to date:
    • Site-wide: 3,315
  • Since beginning of last month:
    • Site-wide: 16,407

Sequencing analysis of the spread of SARS-CoV2 in the Greater New York City region

infectious diseases more details view paper
  • Downloaded 5,948 times
  • Download rankings, all-time:
    • Site-wide: 2,704
    • In infectious diseases: 701
  • Year to date:
    • Site-wide: 14,875
  • Since beginning of last month:
    • Site-wide: 21,681

Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies

microbiology more details view paper
  • Downloaded 5,004 times
  • Download rankings, all-time:
    • Site-wide: 3,405
    • In microbiology: 247
  • Year to date:
    • Site-wide: 13,365
  • Since beginning of last month:
    • Site-wide: 50,199

High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization.

microbiology more details view paper
  • Downloaded 3,404 times
  • Download rankings, all-time:
    • Site-wide: 5,902
    • In microbiology: 380
  • Year to date:
    • Site-wide: 58,674
  • Since beginning of last month:
    • Site-wide: 62,520

SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting

infectious diseases more details view paper
  • Downloaded 3,362 times
  • Download rankings, all-time:
    • Site-wide: 6,023
    • In infectious diseases: 1,169
  • Year to date:
    • Site-wide: 549
  • Since beginning of last month:
    • Site-wide: 15,069

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

infectious diseases more details view paper
  • Downloaded 3,033 times
  • Download rankings, all-time:
    • Site-wide: 6,993
    • In infectious diseases: 2,101
  • Year to date:
    • Site-wide: 636
  • Since beginning of last month:
    • Site-wide: 706

Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease

rheumatology more details view paper
  • Downloaded 2,512 times
  • Download rankings, all-time:
    • Site-wide: 9,199
    • In rheumatology: 7
  • Year to date:
    • Site-wide: 16,959
  • Since beginning of last month:
    • Site-wide: 20,613

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies

immunology more details view paper
  • Downloaded 1,215 times
  • Download rankings, all-time:
    • Site-wide: 28,369
    • In immunology: 1,008
  • Year to date:
    • Site-wide: 3,871
  • Since beginning of last month:
    • Site-wide: 53,274

Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection

immunology more details view paper
  • Downloaded 960 times
  • Download rankings, all-time:
    • Site-wide: 40,799
    • In immunology: 1,368
  • Year to date:
    • Site-wide: 68,679
  • Since beginning of last month:
    • Site-wide: 147,115

COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)

infectious diseases more details view paper
  • Downloaded 893 times
  • Download rankings, all-time:
    • Site-wide: 45,585
    • In infectious diseases: 4,466
  • Year to date:
    • Site-wide: 4,079
  • Since beginning of last month:
    • Site-wide: 2,604

Hydroxychloroquine/Chloroquine for the Treatment of Hospitalized Patients with COVID-19: An Individual Participant Data Meta-Analysis

infectious diseases more details view paper
  • Downloaded 670 times
  • Download rankings, all-time:
    • Site-wide: 69,465
    • In infectious diseases: 4,951
  • Year to date:
    • Site-wide: 6,562
  • Since beginning of last month:
    • Site-wide: 35,456

Optimized Quantification of Intrahost Viral Diversity in SARS-CoV-2 and Influenza Virus Sequence Data

microbiology more details view paper
  • Downloaded 606 times
  • Download rankings, all-time:
    • Site-wide: 79,305
    • In microbiology: None
  • Year to date:
    • Site-wide: 29,864
  • Since beginning of last month:
    • Site-wide: 18,815

Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study

neurology more details view paper
  • Downloaded 563 times
  • Download rankings, all-time:
    • Site-wide: 86,805
    • In neurology: 342
  • Year to date:
    • Site-wide: 8,750
  • Since beginning of last month:
    • Site-wide: 90,279

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity

immunology more details view paper
  • Downloaded 331 times
  • Download rankings, all-time:
    • Site-wide: 145,091
    • In immunology: 4,696
  • Year to date:
    • Site-wide: 66,954
  • Since beginning of last month:
    • Site-wide: 53,130

Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial

infectious diseases more details view paper
  • Downloaded 245 times
  • Download rankings, all-time:
    • Site-wide: 170,153
    • In infectious diseases: 7,601
  • Year to date:
    • Site-wide: 33,514
  • Since beginning of last month:
    • Site-wide: 77,914

Immunological Cross-Reactivity to Dengue Virus among Persons with Neuroinvasive West Nile Virus Infection

infectious diseases more details view paper
  • Downloaded 193 times
  • Download rankings, all-time:
    • Site-wide: 183,283
    • In infectious diseases: 7,648
  • Year to date:
    • Site-wide: 47,129
  • Since beginning of last month:
    • Site-wide: 122,372

Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies

neurology more details view paper
  • Downloaded 172 times
  • Download rankings, all-time:
    • Site-wide: 187,934
    • In neurology: 1,267
  • Year to date:
    • Site-wide: 54,978
  • Since beginning of last month:
    • Site-wide: 166,679

Cellular and Humoral Immunity to Ebola Zaire Glycoprotein and Viral Vector Proteins Following Immunization with Recombinant Vesicular Stomatitis Virus-Based Ebola Vaccine (rVSV{triangleup}G-EBOV-GP)

infectious diseases more details view paper
  • Downloaded 170 times
  • Download rankings, all-time:
    • Site-wide: 188,300
    • In infectious diseases: 7,841
  • Year to date:
    • Site-wide: 97,407
  • Since beginning of last month:
    • Site-wide: 106,835

The Vacc-SeqQC Project: Benchmarking RNA-Seq for Clinical Vaccine Studies

systems biology more details view paper
  • Downloaded 90 times
  • Download rankings, all-time:
    • Site-wide: 202,337
    • In systems biology: 3,778
  • Year to date:
    • Site-wide: 102,696
  • Since beginning of last month:
    • Site-wide: 143,626

PanLingua

News